Microvascular Dysfunction in Obesity-Hypertension

Coronary microvascular dysfunction: A review of recent progress and clinical implications

(2023) Rajan Rehan et al.   Frontiers in Cardiovascular Medicine

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

(2023) Julio Rosenstock et al.   LANCET

New Noninvasive Methods to Evaluate Microvascular Structure and Function

(2022) Damiano Rizzoni et al.   HYPERTENSION

Assessments of microvascular function in organ systems

(2022) Cynthia Xu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Tirzepatide Once Weekly for the Treatment of Obesity

(2022) Ania M. Jastreboff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials

(2022) Chen Gong et al.   Frontiers in Cardiovascular Medicine

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice

(2022) Yimin Tu et al.   Frontiers in Cardiovascular Medicine

Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension

(2021) Tim Gruber et al.   Cell Metabolism

Circadian clock dysfunction in human omental fat links obesity to metabolic inflammation

(2021) Eleonore Maury et al.   Nature Communications

Contributions of obesity to kidney health and disease: insights from Mendelian randomization and the human kidney transcriptomics

(2021) Xiaoguang Xu et al.   CARDIOVASCULAR RESEARCH

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

(2021) Naveed Sattar et al.   Lancet Diabetes & Endocrinology

Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet

(2020) Vijayakumar Sukumaran et al.   Cardiovascular Diabetology

Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue

(2020) Alessandro De Stefano et al.   HYPERTENSION

Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction

(2019) Hannah Elena Suhrs et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cardiovascular Imaging Techniques to Assess Microvascular Dysfunction

(2019) Roshin C. Mathew et al.   JACC-Cardiovascular Imaging

Vasodilatory Actions of Glucagon-Like Peptide 1 Are Preserved in Skeletal and Cardiac Muscle Microvasculature but Not in Conduit Artery in Obese Humans With Vascular Insulin Resistance

(2019) Nasui Wang et al.   DIABETES CARE

Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC

(2017) Venkatesh L. Murthy et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Obesity Induces Artery-Specific Alterations: Evaluation of Vascular Function and Inflammatory and Smooth Muscle Phenotypic Markers

(2017) Antonio Garcia Soares et al.   Biomed Research International

Comprehensive assessment of microcirculation after primary percutaneous intervention in ST-segment elevation myocardial infarction

(2016) Sang-Don Park et al.   CORONARY ARTERY DISEASE

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

(2016)   LANCET

Antiangiogenic Actions of Vascular Endothelial Growth Factor-A 165 b, an Inhibitory Isoform of Vascular Endothelial Growth Factor-A, in Human Obesity

(2014) Doan T.M. Ngo et al.   CIRCULATION

Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue

(2014) Agostino Virdis et al.   EUROPEAN HEART JOURNAL

Vascular rarefaction mediates whitening of brown fat in obesity

(2014) Ippei Shimizu et al.   JOURNAL OF CLINICAL INVESTIGATION

Dilatation of Sinusoidal Capillary and Swelling of Sinusoidal Fenestration in Obesity: An Ultrastructural Study

(2014) Kazuhiko Nakadate et al.   ULTRASTRUCTURAL PATHOLOGY

Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X

(2013) Xinling Zhang et al.   CORONARY ARTERY DISEASE

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

(2013) Ann Wittfeldt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

When Collateral Supply is Accounted For Epicardial Stenosis Does Not Increase Microvascular Resistance

(2012) Jamie Layland et al.   Circulation-Cardiovascular Interventions

High calorie diet triggers hypothalamic angiopathy

(2012) Chun-Xia Yi et al.   Molecular Metabolism

Depot-Specific Differences and Insufficient Subcutaneous Adipose Tissue Angiogenesis in Human Obesity

(2011) Olga Gealekman et al.   CIRCULATION

Effects of Weight Loss on Structural and Functional Alterations of Subcutaneous Small Arteries in Obese Patients

(2011) Carolina De Ciuceis et al.   HYPERTENSION

Beneficial effects of statin treatment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction

(2011) Kentaro Ishida et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Progressive Renal Vascular Proliferation and Injury in Obese Zucker Rats

(2010) RADU ILIESCU et al.   MICROCIRCULATION

Direct medical cost of overweight and obesity in the USA: a quantitative systematic review

(2010) A. G. Tsai et al.   Obesity Reviews

Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women

(2009) John P. Forman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Structural and Functional Alterations of Subcutaneous Small Resistance Arteries in Severe Human Obesity

(2009) Guido Grassi et al.   Obesity